{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:27:17Z","timestamp":1791268037601,"version":"4.1.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1097\/fpc.0b013e32832ee55b","type":"journal-article","created":{"date-parts":[[2009,9,21]],"date-time":"2009-09-21T03:12:59Z","timestamp":1253502779000},"page":"742-750","source":"Crossref","is-referenced-by-count":48,"title":["Consequences of the Y139F Vkorc1 mutation on resistance to AVKs: in-vivo investigation in a 7th generation of congenic Y139F strain of rats"],"prefix":"10.1097","volume":"19","author":[{"given":"Agnes","family":"Grandemange","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Hans","family":"Kohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Lasseur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Longin-Sauvageon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Berny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Benoit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210212","first-page":"1","article-title":"Dietary vitamin K intake and anticoagulationin elderly patients","volume":"10","author":"Rohde","year":"2007","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"R2-2-20210212","first-page":"617","article-title":"A case study of acenocoumarol sensitivity and genotype-phenotype discordancy explained by combinations of polymorphisms in VKORC1 and Cyp2C9","volume":"62","author":"Rettie","year":"2006","journal-title":"Br J ClinPharmacol"},{"key":"R3-2-20210212","doi-asserted-by":"crossref","first-page":"25276","DOI":"10.1074\/jbc.M401645200","article-title":"The inhibitory effect of calumenin on the vitamin K-dependent g-carboxylation system","volume":"279","author":"Wajih","year":"2004","journal-title":"J Biol Chem"},{"key":"R4-2-20210212","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/188517a0","article-title":"Case of apparent resistance of Rattus norvegicus (Berkenhout) to anticoagulant poisons","volume":"188","author":"Boyle","year":"1960","journal-title":"Nature"},{"key":"R5-2-20210212","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0742-8413(93)90106-U","article-title":"The development of a blood clotting response test for discriminating between difenacoum-resistant and susceptible Norway rats (Rattus norvegicus, Berk)","volume":"104","author":"Gill","year":"1993","journal-title":"Comp Biochem Physiol C"},{"key":"R6-2-20210212","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1017\/S0022172400070820","article-title":"Field trials of second-generation anticoagulants against difenacoum-resistant Norway rat populations","volume":"89","author":"Greaves","year":"1982","journal-title":"J Hyg"},{"key":"R7-2-20210212","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1017\/S0022172400069370","article-title":"Trials of the anticoagulant rodenticides bromadiolone and difenacoum against the house mouse (Mus musculus L.)","volume":"87","author":"Rowe","year":"1981","journal-title":"J Hyg"},{"key":"R8-2-20210212","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nature02254","article-title":"Identification of the gene forvitamin K epoxide reductase","volume":"427","author":"Li","year":"2004","journal-title":"Nature"},{"key":"R9-2-20210212","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nature02214","article-title":"Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2","volume":"427","author":"Rost","year":"2004","journal-title":"Nature"},{"key":"R10-2-20210212","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1111\/j.1538-7836.2008.03116.x","article-title":"Pharmacodynamic resistance to warfarin is associated with nucleotide substitutions in VKORC1","volume":"6","author":"Harrington","year":"2008","journal-title":"J Thromb Haemost"},{"key":"R11-2-20210212","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1111\/j.1538-7836.2005.01449.x","article-title":"A vitamin K epoxide reductase complex subunit-1 mutation in a patient with vitamin K antagonist resistance","volume":"3","author":"Bodin","year":"2005","journal-title":"J Thromb Haemost"},{"key":"R12-2-20210212","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1160\/TH04-08-0540","article-title":"Pharmacodynamic resistance to warfarin associated with a Val66Met substitution in vitamin K epoxide reductase complex subunit 1","volume":"93","author":"Harrington","year":"2005","journal-title":"Thromb Haemost"},{"key":"R13-2-20210212","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/jbt.20104","article-title":"Warfarin resistance in a French strain of rats","volume":"19","author":"Lasseur","year":"2005","journal-title":"J BioChem Mol Tox"},{"key":"R14-2-20210212","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1534\/genetics.104.040360","article-title":"The genetic basis of resistance to anticoagulants in rodents","volume":"170","author":"Pelz","year":"2005","journal-title":"Genetics"},{"key":"R15-2-20210212","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/ps.1506","article-title":"Differential expression of cytochrome P450 genes between bromadiolone-resistant and anticoagulant-susceptible Norway rats: a possible role for pharmacokinetics in bromadiolone resistance","volume":"64","author":"Markussen","year":"2008","journal-title":"Pest Manage Sci"},{"key":"R16-2-20210212","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1124\/dmd.106.011775","article-title":"Elevated warfarin metabolism in warfarin-resistant roof rats (Rattus rattus) in Tokyo","volume":"35","author":"Ishizuka","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"R17-2-20210212","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00498250110060932","article-title":"Suppression of CYP3A2 mRNA expression in the warfarin-resistant roof rat, Rattus rattus: possible involvement of cytochrome P450 in the warfarin resistance mechanism","volume":"31","author":"Sugano","year":"2000","journal-title":"Xenobiotica"},{"key":"R18-2-20210212","article-title":"A reappraisal of blood clotting response tests for anticoagulant resistance and a proposal for a standardised BCR test methodology. Technical monograph 2003","year":"2003"},{"key":"R19-2-20210212","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ps.2780430112","article-title":"Warfarin-based rodenticides: mode of action and mechanism of resistance","volume":"43","author":"Thijssen","year":"1995","journal-title":"Pestic Sci"},{"key":"R21-2-20210212","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/215877a0","article-title":"Heritable resistance to warfarin in rats","volume":"215","author":"Greaves","year":"1967","journal-title":"Nature"},{"key":"R22-2-20210212","doi-asserted-by":"crossref","first-page":"7911","DOI":"10.1073\/pnas.97.14.7911","article-title":"Natural selection mapping of the warfarin resistance gene","volume":"97","author":"Kohn","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R23-2-20210212","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s003359901073","article-title":"Genomic assignment of the warfarin resistance locus, Rw, in the rat","volume":"10","author":"Kohn","year":"1999","journal-title":"Mamm Genome"},{"key":"R24-2-20210212","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1182\/blood.V96.5.1996","article-title":"A gene-anchored map position of the rat warfarin resistance locus, Rw, and its orthologs in mouse and human","volume":"96","author":"Kohn","year":"2000","journal-title":"Blood"},{"key":"R25-2-20210212","first-page":"389","article-title":"Current advances in vitamin K research","author":"Greaves","year":"1988"},{"key":"R26-2-20210212","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780195075540.001.0001","article-title":"Mouse genetics: concepts and applications","author":"Silver","year":"1995"},{"key":"R27-2-20210212","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.pestbp.2006.11.005","article-title":"Comparison of the inhibition effect of different anticoagulants on vitamin K epoxide reductase activity from warfarin-susceptible and resistant rat","volume":"88","author":"Lasseur","year":"2007","journal-title":"Pestic Biochem Physiol"}],"container-title":["Pharmacogenetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01213011-200910000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:58:06Z","timestamp":1786039086000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01213011-200910000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/fpc.0b013e32832ee55b","relation":{},"ISSN":["1744-6872"],"issn-type":[{"value":"1744-6872","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}